Hemex Health Stock
Develops malaria and sickle cell diagnostic devices.
About Hemex Health Stock
They seek out and work with brilliant inventors to deliver revolutionary solutions to global health problems. Our innovative products are designed to help millions of people across all markets, especially in underserved areas.
Funding History
| December 2016 | $1.5M |
|---|---|
| June 2017 | $3.0M |
| August 2017 | $25K |
| November 2017 | $600K |
| December 2017 | $1.7M |
Management
CIO
Peter Galen
CEO
Patti White
Vice President Engineering
Daren Bledsoe
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Hemex Health or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
